Amyloid β1–42 oligomer inhibits myelin sheet formation in vitro
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Accumulating evidence indicates that white matter degeneration contributes to the neural disconnections that underlie Alzheimer’s disease pathophysiology. Although this white matter degeneration is partly attributable to axonopathy associated with neuronal degeneration, amyloid β (Aβ) protein-mediated damage to oligodendrocytes could be another mechanism. To test this hypothesis, we studied effects of soluble Aβ in oligomeric form on survival and differentiation of cells of the oligodendroglial lineage using highly purified oligodendroglial cultures from rats at different developmental stages. Aβ oligomer at 10 μM or higher reduced survival of mature oligodendrocytes, whereas oligodendroglial progenitor cells (OPCs) were relatively resistant to the Aβ oligomer-mediated cytotoxicity. Further study revealed that Aβ oligomer even at 1 μM accelerated 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) formazan exocytosis in mature oligodendrocytes, and, more significantly, inhibited myelin sheet formation after induction of in vitro differentiation of OPCs. These results imply a novel pathogenetic mechanism underlying Aβ oligomer-mediated white matter degeneration, which could impair myelin maintenance and remyelination by adult OPCs, resulting in accumulating damage to myelinating axons thereby contributing to neural disconnections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 1×
“Although amyloid (A ) protein aggregation is posited to be the pathologic first step of the AD process (Haass and Selkoe, 2007), A protein can lso be found in relatively high concentration in cerebral hite matter (Roher et al., 2002).”
BackgroundAge-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease
Bartzokis, G. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.03.001 · Cited by 968 · cited 1×
“In humans, cerebral myelination continues until the end of the fifth decade in the prefrontal and other association areas (Baumann and Pham-Dinh, 2001), and recently these latemyelinating neocortical regions have been shown to be most affected by AD (Bartzokis, 2004).”
BackgroundPolydendrocytes (NG2 cells): multifunctional cells with lineage plasticity
Nishiyama, A., Komitova, M., Suzuki, R., & Zhu, X. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2495 · Cited by 865
The cognitive correlates of white matter abnormalities in normal aging: A quantitative review.
Gunning-Dixon, F. M., & Raz, N. (2000) · Neuropsychology · doi:10.1037/0894-4105.14.2.224 · Cited by 794 · cited 1×
“…in the brain, white matter is also critical for many higher order cognitive processes including attention, executive functioning, nonverbal/visual-spatial processing, and generalized processing speed (Gunning-Dixon and Raz, 2000), all of which are invariably impaired in Alzheimer’s disease (AD).”
BackgroundExtent and distribution of white matter hyperintensities in normal aging, MCI, and AD
Yoshita, M., Fletcher, E., Harvey, D., Ortega, M., Martinez, O., Mungas, D. M., Reed, B. R., & DeCarli, C. S. (2006) · Neurology · doi:10.1212/01.wnl.0000249119.95747.1f · Cited by 434
Self-citationRole of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease
Zhao, L., Ma, Q.-L., Calon, F., Harris-White, M. E., Yang, F., Lim, G. P., Morihara, T., Ubeda, O. J., Ambegaokar, S., Hansen, J. E., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1630 · Cited by 317
Lee, J.-T., Xu, J., Lee, J.-M., Ku, G., Han, X., Yang, D.-I., Chen, S., & Hsu, C. Y. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200307017 · Cited by 280
Roher, A. E., Weiss, N., Kokjohn, T. A., Kuo, Y.-M., Kalback, W., Anthony, J., Watson, D., Luehrs, D. C., Sue, L., Walker, D., et al. (2002) · Biochemistry · doi:10.1021/bi026173d · Cited by 279 · cited 4×
“Although amyloid (A ) protein aggregation is posited to be the pathologic first step of the AD process (Haass and Selkoe, 2007), A protein can lso be found in relatively high concentration in cerebral hite matter (Roher et al., 2002).”
BackgroundMethodInfluentialDiffusion tensor imaging in mild cognitive impairment and Alzheimerʼs disease: a review
Chua, T. C., Wen, W., Slavin, M. J., & Sachdev, P. S. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282f4594b · Cited by 273 · cited 2×
“…resonance imaging technique highly sensitive to white matter microstructural changes, has revealed white matter abnormalities particularly in the posterior regions of not only AD patients but also those with mild cognitive impairment (MCI), an early stage of clinical AD (Chua et al., 2008).”
BackgroundResultDesai, M. K., Sudol, K. L., Janelsins, M. C., Mastrangelo, M. A., Frazer, M. E., & Bowers, W. J. (2009) · Glia · doi:10.1002/glia.20734 · Cited by 266 · cited 2×
“…could be another cellular injury mechanism conributing to A protein-mediated white matter degeneration. onsistent with this hypothesis, Desai et al. (2009) recently provided the first ultrastructural evidence of myelination abnormalities in 3xTg-AD mice at ages that precede overt…”
BackgroundResult
Research works printed but not linked: 40
- Abe, 1998, Amyloid β protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes, Neurosci. Res., 31, 295, 10.1016/S0168-0102(98)00055-8 · DOI
- Barber, 1999, White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging, J. Neurol. Neurosurg. Psychiatry, 67, 66, 10.1136/jnnp.67.1.66 · DOI · Paper page
- Baumann, 2001, Biology of oligodendrocyte and myelin in the mammalian central nervous system, Physiol. Rev., 81, 871, 10.1152/physrev.2001.81.2.871 · DOI · Paper page
- Chen, 2006, Amyloid beta peptide increases DP5 expression via activation of neutral sphingomyelinase and JNK in oligodendrocytes, J. Neurochem., 97, 631, 10.1111/j.1471-4159.2006.03774.x · DOI · Paper page
- Cho, 2008, Abnormal integrity of corticocortical tracts in mild cognitive impairment: a diffusion tensor imaging study, J. Korean Med. Sci., 23, 477, 10.3346/jkms.2008.23.3.477 · DOI · Paper page
- de Vries, 1998, An apical-type trafficking pathway is present in cultured oligodendrocytes but the sphingolipid-enriched myelin membrane is the target of a basolateral-type pathway, Mol. Biol. Cell, 9, 599, 10.1091/mbc.9.3.599 · DOI · Paper page
- Debruin, 2007, White matter rafting -membrane microdomains in myelin, Neurochem. Res., 32, 213, 10.1007/s11064-006-9137-4 · DOI
- Diaz, 2007, Localization of MTT formazan in lipid droplets, Eur. J. Histochem., 51, 213
- Gielen, 2006, Rafts in oligodendrocytes: evidence and structure-function relationship, Glia, 54, 499, 10.1002/glia.20406 · DOI · Paper page
- Harms, 2006, Evaluation of white matter integrity in ex vivo brains of amyloid plaque-bearing APPsw transgenic mice using magnetic resonance diffusion tensor imaging, Exp. Neurol., 199, 408, 10.1016/j.expneurol.2006.01.002 · DOI
- Hong, 2007, Combining the rapid MTT formazan exocytosis assay and the MC65 protection assay led to the discovery of carbazole analogs as small molecule inhibitors of Aβ oligomer-induced cytotoxicity, Brain Res., 1130, 223, 10.1016/j.brainres.2006.10.093 · DOI
- Horiuchi, 2006, MEK-ERK signaling is involved in interferon-γ-induced death of oligodendroglial progenitor cells, J. Biol. Chem., 281, 20095, 10.1074/jbc.M603179200 · DOI · Paper page
- Horiuchi, 2010, Differing in vitro survival dependency of mouse and rat NG2+ oligodendroglial progenitor cells, J. Neurosci. Res., 88, 957, 10.1002/jnr.22262 · DOI
- Itoh, 2002, AMPA glutamate receptor-mediated calcium signaling is transiently enhanced during development of oligodendrocytes, J. Neurochem., 81, 390, 10.1046/j.1471-4159.2002.00866.x · DOI · Paper page
- Itoh, 2003, Bcl-2-related protein family gene expression during oligodendroglial differentiation, J. Neurochem., 85, 1500, 10.1046/j.1471-4159.2003.01795.x · DOI
- Itoh, 2000, Diminished calcium homeostasis and increased susceptibility to excitotoxicity of JS, Glia, 31, 165, 10.1002/1098-1136(200008)31:2<165::AID-GLIA80>3.0.CO;2-# · DOI
- Jantaratnotai, 2003, Amyloid β peptide-induced corpus callosum damage and glial activation in vivo, Neuroreport, 14, 1429, 10.1097/00001756-200308060-00005 · DOI · Paper page
- Kadish, 2009, Hippocampal and cognitive aging across the lifespan: a bioenergetic shift precedes and increased cholesterol trafficking parallels memory impairment, J. Neurosci., 29, 1805, 10.1523/JNEUROSCI.4599-08.2009 · DOI · Paper page
- Klein, 2002, Aβ toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets, Neurochem. Int., 41, 345, 10.1016/S0197-0186(02)00050-5 · DOI · Paper page
- Lambert, 1998, Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins, Proc. Natl. Acad. Sci. U. S. A., 95, 6448, 10.1073/pnas.95.11.6448 · DOI · Paper page
- Lintner, 2000, Redistribution of cholesterol in oligodendrocyte membrane sheets after activation of distinct signal transduction pathways, J. Neurosci. Res., 15, 437, 10.1002/(SICI)1097-4547(20000515)60:4<437::AID-JNR2>3.0.CO;2-9 · DOI
- Liu, 2004, Detecting bioactive amyloid β peptide species in Alzheimer's disease, J. Neurochem., 91, 648, 10.1111/j.1471-4159.2004.02751.x · DOI
- Liu, 1997, Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction, J. Neurochem., 69, 581, 10.1046/j.1471-4159.1997.69020581.x · DOI · Paper page
- Liu, 1998, Amyloid β peptide alters intracellular vesicle trafficking and cholesterol homeostasis, Proc. Natl. Acad. Sci. U. S. A., 95, 13266, 10.1073/pnas.95.22.13266 · DOI · Paper page
- Liu, 2001, A cell-based method for the detection of nanomolar concentrations of bioactive amyloid, Anal. Biochem., 289, 130, 10.1006/abio.2000.4928 · DOI
- Ma, 2008, p21-activated kinase-aberrant activation and translocation in Alzheimer disease pathogenesis, J. Biol. Chem., 283, 14132, 10.1074/jbc.M708034200 · DOI · Paper page
- Maezawa, 2008, Congo red and thioflavin-T analogs detect Abeta oligomers, J. Neurochem., 104, 457, 10.1111/j.1471-4159.2007.04972.x · DOI · Paper page
- Maezawa, 2006, Congo red and thioflavin-T analogs detect Abeta oligomers, J. Neurochem., 98, 57, 10.1111/j.1471-4159.2006.03862.x · DOI · Paper page
- Maier, 2009, Lovastatin induces the formation of abnormal myelin-like membrane sheets in primary oligodendrocytes, Glia, 57, 402, 10.1002/glia.20769 · DOI · Paper page
- Maier, 2008, Polarity development in oligodendrocytes: sorting and trafficking of myelin components, J. Mol. Neurosci., 35, 35, 10.1007/s12031-007-9024-8 · DOI
- Nakata, 2009, Diffusion abnormality in the posterior cingulum and hippocampal volume: correlation with disease progression in Alzheimer's disease, Magn. Reson. Imaging, 27, 347, 10.1016/j.mri.2008.07.013 · DOI
- Peters, 2003, Is there remyelination during aging of the primate central nervous system?, J. Comp. Neurol., 460, 238, 10.1002/cne.10639 · DOI · Paper page
- Polito, 2005, NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system, J. Anat., 207, 707, 10.1111/j.1469-7580.2005.00454.x · DOI · Paper page
- Raff, 1983, A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium, Nature, 303, 390, 10.1038/303390a0 · DOI · Paper page
- Song, 2001, Cytoskeletal reorganization during the formation of oligodendrocyte processes and branches, Mol. Cell. Neurosci., 17, 624, 10.1006/mcne.2001.0974 · DOI
- Stokin, 2005, Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease, Science, 307, 1282, 10.1126/science.1105681 · DOI · Paper page
- Taguchi, 2005, Biochemical and morphologic evidence of the interaction of oligodendrocyte membrane rafts with actin filaments, J. Neurosci. Res., 81, 218, 10.1002/jnr.20555 · DOI
- Thomas, 2002, Myosin light chain kinase inhibitors induce retraction of mature oligodendrocyte processes, Neurochem. Res., 27, 1305, 10.1023/A:1021615530960 · doi:10.1023/a:1021615530960
- Zeng, 2005, Amyloid-β peptide enhances tumor necrosis factor-α-induced iNOS through neural sphingomyelinase/ceramide pathway in oligodendrocytes, J. Neurochem., 94, 703, 10.1111/j.1471-4159.2005.03217.x · DOI · Paper page
- Zhou, 2008, Abnormal connectivity in the posterior cingulate and hippocampus in early Alzheimer's disease and mild cognitive impairment, Alzheimers Dement., 4, 265, 10.1016/j.jalz.2008.04.006 · DOI · Paper page
Cited by
White matter changes in Alzheimer’s disease: A focus on myelin and oligodendrocytes
Nasrabady, S. E., Rizvi, B., Goldman, J. E., & Brickman, A. M. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0515-3 · Cited by 723
“It is not clear if these changes are independent of cortical pathology or the cortical structural damages are beyond the detection limits of methods at early stages of the disease [29, 30, 40] and subtle neurodegenerative changes could precede or promote white matter changes even if they are not detectable with conven…”
Zhan, X., Stamova, B., & Sharp, F. R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00042 · Cited by 351
Behrendt, G., Baer, K., Buffo, A., Curtis, M. A., Faull, R. L., Rees, M. I., Götz, M., & Dimou, L. (2013) · Glia · doi:10.1002/glia.22432 · Cited by 219
Hedden, T., Mormino, E. C., Amariglio, R. E., Younger, A. P., Schultz, A. P., Becker, J. A., Buckner, R. L., Johnson, K. A., Sperling, R. A., & Rentz, D. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2462-12.2012 · Cited by 182
Dá Mesquita, S., Ferreira, A. C., Sousa, J. C., Correia-Neves, M., Sousa, N., & Marques, F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.014 · Cited by 166
Metadata
- Authors
- Horiuchi, M., Maezawa, I., Itoh, A., Wakayama, K., Jin, L.-W., Itoh, T., & DeCarli, C.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 33
- Issue
- 3
- Pages
- 499-509
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2018767861
- Cited by
- 84
- References
- 15
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- UC Davis Alzheimer's Disease Center
- National Institute of Health Grant (P30 AG10129, R01 AG025500, R21 AG031362)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amyloid β1–42 oligomer inhibits myelin sheet formation in vitro. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2010.05.007
- The paper
- Horiuchi, M., Maezawa, I., Itoh, A., Wakayama, K., Jin, L.-W., Itoh, T., & DeCarli, C. (2012). Amyloid β1–42 oligomer inhibits myelin sheet formation in vitro. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2010.05.007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.